Ensign Peak Advisors
RGEN icon

Ensign Peak Advisors’s Repligen RGEN Stock Holding History

Ensign Peak Advisors’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.96M Sell
76,020
-25,189
-25% -$3.52M 0.02% 430
2025
Q4 		$16.6M Sell
101,209
-14,557
-13% -$2.28M 0.03% 313
2025
Q3 		$15.5M Sell
115,766
-33,275
-22% -$4.04M 0.03% 366
2025
Q2 		$18.5M Sell
149,041
-8,638
-5% -$1.1M 0.03% 332
2025
Q1 		$20.1M Buy
157,679
+19,610
+14% +$3.02M 0.04% 304
2024
Q4 		$19.9M Sell
138,069
-1,106
-0.8% -$159K 0.04% 326
2024
Q3 		$20.7M Buy
139,175
+50,357
+57% +$7.22M 0.04% 321
2024
Q2 		$11.2M Sell
88,818
-22,803
-20% -$3.57M 0.02% 417
2024
Q1 		$20.5M Buy
111,621
+63,752
+133% +$12.1M 0.04% 320
2023
Q4 		$8.61M Buy
47,869
+2,365
+5% +$368K 0.02% 476
2023
Q3 		$7.24M Buy
45,504
+235
+0.5% +$38.4K 0.02% 474
2023
Q2 		$6.4M Buy
45,269
+3,470
+8% +$556K 0.01% 523
2023
Q1 		$7.04M Buy
41,799
+3,607
+9% +$644K 0.02% 481
2022
Q4 		$6.47M Buy
38,192
+296
+0.8% +$53.7K 0.01% 500
2022
Q3 		$7.09M Sell
37,896
-2,103
-5% -$443K 0.02% 439
2022
Q2 		$6.5M Sell
39,999
-5,076
-11% -$803K 0.02% 468
2022
Q1 		$8.48M Buy
45,075
+179
+0.4% +$34K 0.02% 463
2021
Q4 		$11.9M Sell
44,896
-18,228
-29% -$4.91M 0.02% 424
2021
Q3 		$18.2M Buy
63,124
+3,355
+6% +$861K 0.04% 331
2021
Q2 		$11.9M Sell
59,769
-1,156
-2% -$224K 0.02% 395
2021
Q1 		$11.8M Buy
60,925
+7,722
+15% +$1.58M 0.03% 390
2020
Q4 		$10.2M Hold
53,203
– – 0.02% 416
2020
Q3 		$7.85M Buy
53,203
+9,521
+22% +$1.36M 0.02% 495
2020
Q2 		$5.4M Buy
43,682
+5,365
+14% +$631K 0.01% 593
2020
Q1 		$3.7M Buy
38,317
+2,300
+6% +$222K 0.01% 601
2019
Q4 		$3.33M Buy
+36,017
New +$3.03M 0.01% 796

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Ensign Peak Advisors's RGEN Position: Q1 2026 in Review

Ensign Peak Advisors reduced its Repligen (RGEN) stake by 25% in Q1 2026, selling an estimated $3.52M and leaving 76,020 shares worth $8.96M. The position accounts for 0.02% of the portfolio, ranked #430.

Ensign Peak Advisors first reported a position in RGEN in Q4 2019 and has held it in 26 quarters since. The position peaked at $20.7M in Q3 2024. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Ensign Peak Advisors held 76,020 shares of Repligen worth $8.96M as of Q1 2026.
  • Ensign Peak Advisors sold 25,189 Repligen shares in Q1 2026, an estimated $3.52M.
  • Repligen made up 0.02% of Ensign Peak Advisors's portfolio in Q1 2026, its #430 holding.
  • Ensign Peak Advisors first reported a position in Repligen in Q4 2019 and has held it in 26 quarters since.
  • Ensign Peak Advisors's Repligen position peaked at $20.7M in Q3 2024.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Ensign Peak Advisors's 13F filing for Q1 2026, filed 13 May 2026.